Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than venography for assessing lesion severity and proper venous stent size -Fabio Verzini: EVAR devices -Armando Mansilha: Vein thrombosis -Profile: Vincent Riambau
